|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-3-20
|
|
pubmed:abstractText |
Previous studies have examined the relation between postmenopausal estrogen replacement therapy (ERT) and the risk of Alzheimer disease (AD). The findings have been inconsistent, since some studies have been interpreted as showing a protective effect while others have reported no effect.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0003-9942
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
435-40
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11255447-Aged,
pubmed-meshheading:11255447-Alzheimer Disease,
pubmed-meshheading:11255447-Case-Control Studies,
pubmed-meshheading:11255447-Cohort Studies,
pubmed-meshheading:11255447-Estrogen Replacement Therapy,
pubmed-meshheading:11255447-Estrogens,
pubmed-meshheading:11255447-Female,
pubmed-meshheading:11255447-Follow-Up Studies,
pubmed-meshheading:11255447-Humans,
pubmed-meshheading:11255447-Postmenopause,
pubmed-meshheading:11255447-Progestins,
pubmed-meshheading:11255447-Risk Factors
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease.
|
|
pubmed:affiliation |
Framingham Heart Study and Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
